google_counter
Diagnosis & treatment / page 2
Get Your Case Reviewed by Our Experts
Professional review, clear next steps.
header icon
CareForward by Booking Health — Helping Patients Help Others

Medical Blog About Treatment Abroad

Welcome to our medical blog – it is dedicated to empowering patients with knowledge about global healthcare! We created this platform with the intention to bridge the gap between patients and the medical innovations available globally.

What's Inside: Discover new and rare methods in oncology, immunology, heart surgery, neurosurgery, and other medical fields! Our health travel insights show how medical journeys open new possibilities with advanced treatments unavailable locally, including specialized cancer care abroad.

Who Benefits: This resource is for patients and their families who seek new treatment methods and explore options at leading international hospitals. Those who want to make informed healthcare decisions beyond borders.

Why Read: Booking Health experts provide verified information through patient-friendly articles – they translate complex medical advances into accessible info. Stay current with the latest developments in global healthcare and discover how international medicine can transform treatment outcomes!

Browse our latest articles and take the first step toward better health outcomes!

Diagnosis & treatment - page 2

placeholder Dendritic Cell Therapy for Lung Cancer Treatment

Imagine a treatment that activates your own immunity to target lung cancer, causing almost no side effects and allowing you to maintain your usual rhythm of life. Dendritic cell therapy opens up this possibility for patients at different stages of the disease, demonstrating an effectiveness of 50-65% for...

placeholder German Ophthalmology - Treatment of Eye Diseases in German Hospitals

The German ophthalmological community is one of the oldest in Europe. To date, it is over 100 years old. The powerful development of ophthalmology in Germany began in 1857. What is interesting to consider is what was fantasy at that time. Today is just the modern reality of treating eye diseases. Each world state...

placeholder Immunotherapy for Liver Cancer

Hepatocellular carcinoma (HCC) is the most widespread form of liver cancer, and it is believed to be one of the leading causes of cancer-related deaths on earth. The epidemiology of liver cancer has changed considerably over the past few decades. Between 1978 and 2012, the incidence of primary liver cancer declined...

placeholder Treatment of Autism in the focused Foreign Clinics

Autism is a mental disorder that is diagnosed in 2% of children. The etiology of the illness is unknown, as there is no single mechanism responsible for of its occurrence. Autism manifests itself with antisocial behavior, lack of communication skills, a tendency to rituals in behavior and systematization. The autistic child does not come...

placeholder NanoKnife® (IRE) Treatment for Prostate Cancer

Prostate cancer (PCa) is one of the most common malignancies in the world and the cause of a significant proportion of all cancer deaths. An understanding of the epidemiology and risk factors of the disease is important since they each relate directly to therapeutic strategies and outcomes of prostate cancer.

placeholder German Clinic of Advanced Biological Medicine Presents New Ways of Cancer Treatment

Cancer is one of the most common causes of human deaths, along with cardiovascular pathologies. A complete cure or effective treatment has not been developed yet. Moreover, traditional therapy may not bring results to its advanced stage, so patients simply receive symptomatic treatment.

placeholder Immunotherapy for melanoma in Germany

According to MDPI clinical data, melanoma accounts for 1.7% of global cancer diagnoses and is the fifth most common cancer in the US. Melanoma incidence is rising in developed, predominantly fair-skinned countries, growing over 320% in the US since 1975. That is why it is very important to look for new effective treatments...

placeholder Treatment of stage 4 liver cancer in Germany

Liver cancer typically strikes between the ages of 50 and 65, ranking as the 5th most common cancer in men and 9th in women. The sobering reality is that three-quarters of cases go undetected until the disease has already spread – a stage 4 diagnosis that traditionally meant a prognosis measured in months, not years.